Filters

COVID-19

The George Institute for Global Health is a global medical research institute that focuses on non-communicable diseases and injury.  With centres in four countries (Australia, China, India and the UK) and offices and staff in many others, we are monitoring the evolving COVID-19 situation.  As a global organisation experienced in operating across time zones with flexible working hours, we are well suited to working remotely and continuing to deliver on our mission to improve the health of millions of people worldwide.  A major focus for us is the safety and well-being of our staff across the globe and we are putting in place plans to ensure they are supported in their work and life, tailored for each setting we are in.    The George Institute will be monitoring external events and adjusting accordingly, with our staff, partners and research programs, front of mind. The importance of chronic disease co-morbidity in terms of the impact of COVID-19 infe

Health systems science

Affordable healthcare is a cornerstone of health equity, yet it remains out of reach for millions globally. This lack of access leaves preventable and treatable conditions unmanaged, driving avoidable suffering, increased morbidity, and higher mortality rates.

New study recommends measures to address stigma faced by burn survivors in health facilities

News / Media release

Changing policy and practice

We conduct large scale work to influence global health policies and practice. For example, a large scale cohort study recruiting 40,000 people in 21 low and middle-income countries is informing development of better fracture care in resource-poor settings. In India, we have reviewed national injury surveillance systems and made recommendations to Government regarding their strengthening and expansion. We evaluated the pilot cashless scheme of health insurance for road crashes victims and made recommendations for effective coverage and performance benchmarking. The findings have contributed to expansion of the scheme across all National Highway’s in India , under the Motor Vehicle (Amendment) bill 2016.

World Safety 2024 event - building a safer future for all

The 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) co-sponsored by the World Health Organization will be held between 2nd-4th September 2024 at Taj Palace, New Delhi (India). This event will focus worldwide attention on safety and injury prevention. The event is hosted by The George Institute for Global Health in collaboration with three other WHO Collaborating Centres in the region:  Transportation Research and Injury Prevention Center (TRIP) at the Indian Institute of Technology (IIT) Delhi Department of Emergency Medicine, All India Institute for Medical Sciences (AIIMS) Department of Epidemiology, National Institute of Mental Health and Neuro Sciences (NIMHANS) All the international experts in the field will gather at this event with a united goal of “Building a safer future for all: Equitable and sustainable strategies for injury and violence prevention”. Why is the George Ins

Funds for innovative program using dance to connect Aboriginal children to culture to improve health and wellbeing

News / Media release

Injury and trauma

Injury is the leading cause of death and disability among working-age individuals, yet it remains an often overlooked global health challenge.

Urgent call for policy reform to ensure global equity in organ transplantation

News / Media release

Community-led study secures $5M to address rates of injury in Indigenous children

News

Injury team secures funding to study how age and sex affect reactions to car alerts

News / Funding success

George Institute research team wins MRFF funding to help transform primary care

News / Funding success

Professor Manuela Ferreira

Profile

Professor Ferreira is NHMRC Investigator Fellow, Professor of Musculoskeletal Health and Program Head, Musculoskeletal Health, at The George Institute for Global Health, where she conducts research on the mechanisms, prognosis and management of musculoskeletal disorders with a focus on low back pain. Before joining The George Institute, she was Professor of Musculoskeletal Health at the University of Sydney, where she was inaugural chair of the Musculoskeletal Priority Research Area (+80 researchers) at the Kolling Institute, and co-chair of the Musculoskeletal Clinical Advisory Group of Sydney Health Partners (an NHMRC, Sydney University and health district research translation partnership). With +320 scientific publications, and +AUD30M in research funding, she is the 2nd highest ranked researcher in the world for ‘low back pain’ (of a total of 33,000 authors worldwide – Expertscape). She currently leads multiple randomised controlled trials of musculoskeletal interventions, including the first placebo randomised controlled trial of spinal surgery, an NHMRC-funded study that will establish the efficacy of decompressive surgery for lumbar spinal stenosis.